# ImmunoTEP With 68-Ga in Metastatic Colo Rectal Cancer

> **NCT02587247** · PHASE2 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 11 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** TF2 antibody/68Ga-IMP-288

## Key facts

- **NCT ID:** NCT02587247
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2022-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02587247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02587247, "ImmunoTEP With 68-Ga in Metastatic Colo Rectal Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02587247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*